[Federal Register Volume 68, Number 63 (Wednesday, April 2, 2003)]
[Notices]
[Pages 16088-16089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-7825]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 22, 2002, October 9, 
2002, and November 7, 2002, Cody Laboratories, Inc., 331 33rd Street, 
Cody, Wyoming 82414, made application by three separate letters to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic class of Schedule I and II controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Methamphetamine (1105).....................  II
Amphetamine (1100).........................  II

[[Page 16089]]

 
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Phenylacetone (8501).......................  II
Oxycodone (9143)...........................  II
------------------------------------------------------------------------

    The firm plans to produce bulk product and finished dosage units 
for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Drug Operations Section, Domestic Drug 
Unit (ODOD) and must be filed no later than June 2, 2003.

    Dated: March 11, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-7825 Filed 4-1-03; 8:45 am]
BILLING CODE 4410-09-M